Building Medical Synergies to Elevate Patient Impact

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Patient-Focused Impact: Building Synergies Across Medical Teams”

STUDY OVERVIEW

As Medical Affairs expands its role across the product and patient journey, the ability to operate as a coordinated, insight-driven ecosystem has become a major differentiator. Fragmented teams miss signals, duplicate work, and dilute impact, while connected Medical organizations accelerate insight flow, unify engagement priorities, and adopt technology more effectively.

This study from Best Practices, LLC explores how leading companies build both operational and strategic synergies across Medical functions. It delves into models for aligning analytics, evidence generation, field operations, and scientific content—supported by trusted data infrastructure, shared dashboards, and AI-enabled tools. The research also highlights the cultural shifts needed to strengthen collaboration, including transparency, change readiness, and cross-functional trust.

Drawing on benchmarks across large, mid-small, connected, and siloed organizations, this study gives senior Medical Affairs leaders a roadmap for creating a truly integrated Medical model—one that strengthens execution, accelerates learning, and elevates the organization’s collective ability to improve patient outcomes.

KEY TOPICS

Operational and strategic connectedness benchmarks
Best practices for cross-team collaboration
Future opportunities for integrated Medical Affairs models

KEY METRICS

Operational synergies across Medical teams
Strategic synergies across Medical teams

SAMPLE KEY FINDINGS

Future opportunities: Amid a period of rapid transformation and disruption, Medical teams crave long-term clarity from leadership, launch excellence support, validated field impact models, tech-driven efficiencies, and support for achieving strategic cross-functional alignment.

METHODOLOGY

Best Practices LLC conducted a benchmark survey with 27 Medical Affairs leaders from 21 biopharma companies, supplemented by deep-dive interviews to capture real-world examples and strategic insights.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care; Clinical Research; Laboratories

Companies Profiled:
AbbVie; ADVANZ PHARMA; Alnylam Pharmaceuticals; argenx; Arrowhead Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Biogen; Boehringer Ingelheim; Cytokinetics; Eva Pharma; Ferring Pharmaceuticals; Gr�nenthal; Insmed; Jazz Pharmaceuticals; Merck; Otsuka; Sanofi; Vertex Pharmaceuticals; Xenon Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Patient-Focused Impact: Building Synergies Across Medical Teams

ID: 5903

Features:

Pages/Slides: 31

Published: 2025

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D3248D34FBA518C800258D4F004F3175
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-patient-focused-impact-building-medical-synergies?opendocument
18
19opendocument
2018.97.9.172
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB